Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III

Clinical trial NCT05886829 · COMPLETED

Trial details

NCT number: NCT05886829
Sponsor: Dr. Ferrer BioPharma
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

COVID-19 Symptoms and Signs COVID-19 Pandemic Coronavirus Disease 2019 Coronavirus Infections

Start date: 2022-07-27
Primary completion: 2023-01-19
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.